PEG-LHRH analog conjugates
    61.
    发明授权
    PEG-LHRH analog conjugates 失效
    PEG-LHRH类似物共轭物

    公开(公告)号:US07268210B2

    公开(公告)日:2007-09-11

    申请号:US11135475

    申请日:2005-05-24

    IPC分类号: A61K38/24 C07K17/00 C07K7/00

    CPC分类号: A61K47/60

    摘要: PEG-LHRH analog conjugates, where a PEG moiety is covalently bound to a serine residue of a LHRH analog, and methods for producing these conjugates are provided in the present invention. Also provided are a pharmaceutical composition and a method for treating pathologies in which LHRH analog administration is beneficial.

    摘要翻译: PEG-LHRH类似物缀合物,其中PEG部分与LHRH类似物的丝氨酸残基共价结合,并且本发明提供了制备这些缀合物的方法。 还提供了用于治疗LHRH类似物给药有益的病理学的药物组合物和方法。

    PEG-LHRH analog conjugates
    63.
    发明授权

    公开(公告)号:US06433135B1

    公开(公告)日:2002-08-13

    申请号:US09698134

    申请日:2000-10-30

    IPC分类号: A61K3824

    CPC分类号: A61K47/60

    摘要: PEG-LHRH analog conjugates, where a PEG moiety is covalently bound to a serine residue of a LHRH analog either directly or via a bifunctional linker molecule, such as an amino acid, and methods for producing these conjugates are provided in the present invention. Also provided are a pharmaceutical composition and a method for treating pathologies in which LHRH analog administration is beneficial.

    Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation
    65.
    发明授权
    Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation 有权
    异双功能聚(乙二醇)衍生物及其制备方法

    公开(公告)号:US08940801B2

    公开(公告)日:2015-01-27

    申请号:US12620011

    申请日:2009-11-17

    CPC分类号: C08G65/3322 C08G65/329

    摘要: This invention provides a method related to the preparation of derivatives of poly(ethylene glycol), wherein the method comprises increasing the pH of an aqueous composition comprising a poly(ethylene glycol) bearing a —O—(CH2)n—CO2R3 functional group to result in an aqueous composition comprising a poly(ethylene glycol) bearing a —O—(CH2)n—CO2H functional group, wherein R3 is alkyl and (n) in each instance is 1-6.

    摘要翻译: 本发明提供了与制备聚(乙二醇)衍生物有关的方法,其中该方法包括将含有-O-(CH 2)n -CO 2 R 3官能团的聚(乙二醇)的含水组合物的pH提高到 得到包含含有-O-(CH 2)n -CO 2 H官能团的聚(乙二醇)的水性组合物,其中R 3是烷基,(n)各自为1-6。

    POLYMER FACTOR VIII MOIETY CONJUGATES
    67.
    发明申请
    POLYMER FACTOR VIII MOIETY CONJUGATES 有权
    聚合物因子VIII MOIETY CONJUGATES

    公开(公告)号:US20120244597A1

    公开(公告)日:2012-09-27

    申请号:US13431872

    申请日:2012-03-27

    IPC分类号: C12N9/96

    CPC分类号: A61K38/37 A61K47/10 A61K47/60

    摘要: Conjugates of a Factor VIII moiety and one or more water-soluble polymers are provided. Typically, the water-soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided are compositions comprising the conjugates, methods of making the conjugates, and methods of administering compositions comprising the conjugates to a patient.

    摘要翻译: 提供因子VIII部分和一种或多种水溶性聚合物的共轭物。 通常,水溶性聚合物是聚(乙二醇)或其衍生物。 还提供了包含缀合物的组合物,制备缀合物的方法,以及向患者施用包含缀合物的组合物的方法。

    Stereoselective reduction of a morphinone
    68.
    发明授权
    Stereoselective reduction of a morphinone 有权
    吗啡酮的立体选择性还原

    公开(公告)号:US08183376B2

    公开(公告)日:2012-05-22

    申请号:US12297632

    申请日:2007-04-19

    IPC分类号: C07D489/02

    CPC分类号: C07D489/02 Y02P20/55

    摘要: A synthetic method is provided, wherein the method comprises stereoselectively reducing a ketone of a morphinone to form a reduced morphinone and optionally covalently attaching a water soluble polymer to the reduced morphinone.

    摘要翻译: 提供了一种合成方法,其中所述方法包括立体选择性还原吗啡酮的酮以形成还原的吗啡酮并且任选地将水溶性聚合物共价连接到还原的吗啡酮上。

    Polymer factor VIII moiety conjugates
    70.
    发明授权
    Polymer factor VIII moiety conjugates 有权
    聚合物因子VIII部分共轭物

    公开(公告)号:US08143378B2

    公开(公告)日:2012-03-27

    申请号:US12636635

    申请日:2009-12-11

    IPC分类号: A61K35/14

    CPC分类号: A61K38/37 A61K47/10 A61K47/60

    摘要: Conjugates of a Factor VIII moiety and one or more water-soluble polymers are provided. Typically, the water-soluble polymer is poly(ethylene glycol) or a derivative thereof. Also provided are compositions comprising the conjugates, methods of making the conjugates, and methods of administering compositions comprising the conjugates to a patient.

    摘要翻译: 提供因子VIII部分和一种或多种水溶性聚合物的共轭物。 通常,水溶性聚合物是聚(乙二醇)或其衍生物。 还提供了包含缀合物的组合物,制备缀合物的方法,以及向患者施用包含缀合物的组合物的方法。